Comparative study on the immunogenicity between an HLA-A24-restricted cytotoxic T-cell epitope derived from survivin and that from its splice variant survivin-2B in oral cancer pat... by Yamaguchi Akira, Miyazaki Akihiro, Idenoue Satomi, Hirohashi Yoshihiko, Torigoe Toshihiko, Kobayashi Jun-ichi, Hiratsuka Hiroyoshi, Sato Noriyuki

Get full text

Aberrant expression and potency as a cancer immunotherapy target of alpha-methylacyl-coenzyme A racemase in prostate cancer by Masumori Naoya, Sato Eiji, Kitamura Hiroshi, Hirohashi Yoshihiko, Torigoe Toshihiko, Honma Ichiya, Tamura Yasuaki, Tsukamoto Taiji, Sato Noriyuki

Get full text

Clinical and immunological evaluation of anti-apoptosis protein, survivin-derived peptide vaccine in phase I clinical study for patients with advanced or recurrent breast cancer by Asanuma Hiroko, Hirohashi Yoshihiko, Yagihashi Atsuhito, Toyota Nobuhiko, Torigoe Toshihiko, Kimura Yasutoshi, Yamaguchi Koji, Furuhata Tomohisa, Hata Fumitake, Katsuramaki Tadashi, Ohmura Tosei, Iwayama Yuji, Tsuruma Tetsuhiro, Shimozawa Kumiko, Okazaki Minoru, Mizushima Yasuhiro, Nomura Naohiro, Sato Noriyuki, Hirata Koichi

Get full text

Phase I clinical study of anti-apoptosis protein, survivin-derived peptide vaccine therapy for patients with advanced or recurrent colorectal cancer by Minamida Hidetoshi, Mizushima Yasuhiro, Sasaki Kazuaki, Yasoshima Takahiro, Katsuramaki Tadashi, Yamaguchi Koji, Ohmura Tosei, Yagihashi Atsuhito, Yamamoto Masaaki, Kurotaki Takehiro, Idenoue Satomi, Furuhata Tomohisa, Torigoe Toshihiko, Hata Fumitake, Tsuruma Tetsuhiro, Kimura Hiromichi, Akiyama Morifumi, Hirohashi Yoshihiko, Asanuma Hiroko, Tamura Yasuaki, Shimozawa Kumiko, Sato Noriyuki, Hirata Koichi

Get full text